Simplicity Wealth LLC Grows Stock Position in CME Group Inc. (NASDAQ:CME)

Simplicity Wealth LLC boosted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 13.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,198 shares of the financial services provider’s stock after buying an additional 141 shares during the quarter. Simplicity Wealth LLC’s holdings in CME Group were worth $278,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. Lake Street Advisors Group LLC grew its position in shares of CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after purchasing an additional 6,453 shares in the last quarter. Meyer Handelman Co. purchased a new position in shares of CME Group in the fourth quarter valued at $6,144,000. Spire Wealth Management grew its position in shares of CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after purchasing an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc grew its position in shares of CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after purchasing an additional 52,862 shares in the last quarter. Finally, Bank of Montreal Can grew its position in shares of CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after purchasing an additional 303,169 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. The trade was a 34.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 17,076 shares of company stock valued at $4,271,496. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CME. Oppenheimer lifted their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. JPMorgan Chase & Co. lifted their price objective on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Piper Sandler lifted their price objective on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $238.93.

View Our Latest Stock Analysis on CME Group

CME Group Trading Up 3.0 %

Shares of CME stock opened at $262.28 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The business has a 50-day moving average price of $240.68 and a two-hundred day moving average price of $231.22. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $262.51. The firm has a market cap of $94.51 billion, a P/E ratio of 27.12, a price-to-earnings-growth ratio of 6.76 and a beta of 0.53.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group declared that its Board of Directors has initiated a share repurchase plan on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to reacquire up to 3.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board of directors believes its shares are undervalued.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date of this dividend is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is 51.71%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.